Fremeau Robert Thomas Jr. Insider Trades

Insider Trading History

Track insider trading activity for Fremeau Robert Thomas Jr.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cancer Genetics
Cancer Genetics CGIX
Chief Scientific Officer
Holding Value $346k 75,000 shares
Last Trade
Mar 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$346k 75,000 shares
$4.61
$4.61
Vyant Bio
Vyant Bio VYNT
Chief Scientific Officer
Holding Value $14.6k 75,000 shares
Last Trade
Mar 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$375k 75,000 shares
$5.00
$0.19
Cancer Genetics
Cancer Genetics CGIX
Chief Scientific Officer
Holding Value $1.15M 250,000 shares
Last Trade
Nov 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.15M 250,000 shares
$4.61
$4.61
Vyant Bio
Vyant Bio VYNT
Chief Scientific Officer
Holding Value $48.5k 250,000 shares
Last Trade
Nov 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.19M 250,000 shares
$12.75
$0.19
Cancer Genetics
Cancer Genetics CGIX
Chief Scientific Officer
Holding Value $4.61k 1,000 shares
Last Trade
Oct 28, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.61k 1,000 shares
$4.61
$4.61
Vyant Bio
Vyant Bio VYNT
Chief Scientific Officer
Holding Value $194 1,000 shares
Last Trade
Oct 28, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.9k 1,000 shares
$10.85
$0.19

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up